↓ Skip to main content

Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression

Overview of attention for article published in Cancer and Metastasis Reviews, November 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news
1 news outlet
twitter
1 X user
facebook
1 Facebook page

Citations

dimensions_citation
441 Dimensions

Readers on

mendeley
353 Mendeley
citeulike
2 CiteULike
Title
Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression
Published in
Cancer and Metastasis Reviews, November 2011
DOI 10.1007/s10555-011-9340-x
Pubmed ID
Authors

Paolo Cirri, Paola Chiarugi

Abstract

Several recent papers have now provided compelling experimental evidence that the progression of tumours towards a malignant phenotype does not depend exclusively on the cell-autonomous properties of cancer cells themselves but is also deeply influenced by tumour stroma reactivity, thereby undergoing a strict environmental control. Tumour microenvironmental elements include structural components such as the extracellular matrix or hypoxia as well as stromal cells, either resident cells or recruited from circulating precursors, as macrophages and other inflammatory cells, endothelial cells and cancer-associated fibroblasts (CAFs). All these elements synergistically play a specific role in cancer progression. This review summarizes our current knowledge on the role of CAFs in tumour progression, with a particular focus on the biunivocal interplay between CAFs and cancer cells leading to the activation of the epithelial-mesenchymal transition programme and the achievement of stem cell traits, as well as to the metabolic reprogramming of both stromal and cancer cells. Recent advances on the role of CAFs in the preparation of metastatic niche, as well as the controversial origin of CAFs, are discussed in light of the new emerging therapeutic implications of targeting CAFs.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 353 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 4 1%
Germany 3 <1%
United Kingdom 2 <1%
Spain 2 <1%
Japan 2 <1%
Saudi Arabia 1 <1%
Netherlands 1 <1%
France 1 <1%
Portugal 1 <1%
Other 0 0%
Unknown 336 95%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 96 27%
Researcher 65 18%
Student > Master 46 13%
Student > Bachelor 38 11%
Student > Doctoral Student 17 5%
Other 52 15%
Unknown 39 11%
Readers by discipline Count As %
Agricultural and Biological Sciences 98 28%
Biochemistry, Genetics and Molecular Biology 77 22%
Medicine and Dentistry 66 19%
Engineering 16 5%
Immunology and Microbiology 10 3%
Other 28 8%
Unknown 58 16%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 October 2022.
All research outputs
#2,893,802
of 23,555,482 outputs
Outputs from Cancer and Metastasis Reviews
#57
of 829 outputs
Outputs of similar age
#22,554
of 242,707 outputs
Outputs of similar age from Cancer and Metastasis Reviews
#3
of 20 outputs
Altmetric has tracked 23,555,482 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 829 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 242,707 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.